Christopher Fortner, MD, PHD

NPI: 1104084078
Total Payments
$59,815
2024 Payments
$269.99
Companies
8
Transactions
79

Payment Breakdown by Category

Travel$22,318 (37.3%)
Consulting$18,438 (30.8%)
Other$16,943 (28.3%)
Food & Beverage$1,914 (3.2%)
Education$202.35 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $22,318 22 37.3%
Consulting Fee $18,438 5 30.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,618 8 27.8%
Food and Beverage $1,914 39 3.2%
Honoraria $325.00 1 0.5%
Education $202.35 4 0.3%

Top Paying Companies

Company Total Records Latest Year
VERTEX PHARMACEUTICALS INCORPORATED $55,402 60 $0 (2024)
Gilead Sciences, Inc. $3,490 11 $0 (2018)
Welch Allyn $325.00 1 $0 (2020)
AbbVie, Inc. $202.21 2 $0 (2017)
Mylan Specialty L.P. $155.82 1 $0 (2024)
HARMONY BIOSCIENCES LLC $84.99 1 $0 (2024)
Novartis Pharmaceuticals Corporation $77.87 1 $0 (2017)
Chiesi USA, Inc. $77.36 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $269.99 3 Mylan Specialty L.P. ($155.82)
2023 $4,548 4 Vertex Pharmaceuticals Incorporated ($4,548)
2022 $6,854 4 Vertex Pharmaceuticals Incorporated ($6,790)
2020 $5,621 7 VERTEX PHARMACEUTICALS INCORPORATED ($5,282)
2019 $8,776 16 VERTEX PHARMACEUTICALS INCORPORATED ($8,776)
2018 $23,835 15 Vertex Pharmaceuticals Incorporated ($23,725)
2017 $9,912 30 VERTEX PHARMACEUTICALS INCORPORATED ($6,252)

All Payment Transactions

79 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
10/14/2024 Mylan Specialty L.P. TOBI PODHALER (Drug) Food and Beverage In-kind items and services $155.82 General
Category: Aminoglycosides
09/24/2024 HARMONY BIOSCIENCES LLC WAKIX (Drug) Education Cash or cash equivalent $84.99 General
Category: Narcoplepsy
06/07/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $29.18 General
12/13/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $2,000.00 General
11/01/2023 Vertex Pharmaceuticals Incorporated Food and Beverage In-kind items and services $54.30 General
11/01/2023 Vertex Pharmaceuticals Incorporated Food and Beverage In-kind items and services $18.38 General
09/08/2023 Vertex Pharmaceuticals Incorporated ORKAMBI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,475.00 General
Category: CYSTIC FIBROSIS
10/05/2022 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $3,150.00 General
07/31/2022 Vertex Pharmaceuticals Incorporated KALYDECO Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,600.00 General
07/08/2022 Vertex Pharmaceuticals Incorporated ORKAMBI (Drug) Education In-kind items and services $40.00 General
Category: CYSTIC FIBROSIS
04/08/2022 Chiesi USA, Inc. BRONCHITOL (Drug) Education Cash or cash equivalent $63.71 General
Category: CYSTIC FIBROSIS
07/22/2020 CHIESI USA, INC. PERTZYE (Drug) Education Cash or cash equivalent $13.65 General
Category: CYSTIC FIBROSIS
05/12/2020 Welch Allyn iExaminer Image Reader (Device), Digital MacroView Otoscope, PanOptic Ophthalmoscope Honoraria Cash or cash equivalent $325.00 General
Category: Physical Assessment, Vision
01/16/2020 VERTEX PHARMACEUTICALS INCORPORATED TRIKAFTA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,547.50 General
Category: CYSTIC FIBROSIS
01/10/2020 VERTEX PHARMACEUTICALS INCORPORATED TRIKAFTA (Drug) Food and Beverage In-kind items and services $58.63 General
Category: CYSTIC FIBROSIS
01/09/2020 VERTEX PHARMACEUTICALS INCORPORATED TRIKAFTA (Drug) Travel and Lodging In-kind items and services $331.98 General
Category: CYSTIC FIBROSIS
01/09/2020 VERTEX PHARMACEUTICALS INCORPORATED TRIKAFTA (Drug) Travel and Lodging In-kind items and services $231.75 General
Category: CYSTIC FIBROSIS
01/03/2020 VERTEX PHARMACEUTICALS INCORPORATED TRIKAFTA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,112.50 General
Category: CYSTIC FIBROSIS
11/20/2019 VERTEX PHARMACEUTICALS INCORPORATED TRIKAFTA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $445.00 General
Category: CYSTIC FIBROSIS
10/17/2019 VERTEX PHARMACEUTICALS INCORPORATED SYMDEKO (Drug) Food and Beverage In-kind items and services $20.15 General
Category: CYSTIC FIBROSIS
10/17/2019 VERTEX PHARMACEUTICALS INCORPORATED SYMDEKO (Drug) Travel and Lodging In-kind items and services $18.00 General
Category: CYSTIC FIBROSIS
10/17/2019 VERTEX PHARMACEUTICALS INCORPORATED SYMDEKO (Drug) Travel and Lodging In-kind items and services $18.00 General
Category: CYSTIC FIBROSIS
10/17/2019 VERTEX PHARMACEUTICALS INCORPORATED SYMDEKO (Drug) Food and Beverage In-kind items and services $6.83 General
Category: CYSTIC FIBROSIS
10/03/2019 VERTEX PHARMACEUTICALS INCORPORATED SYMDEKO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,435.00 General
Category: CYSTIC FIBROSIS
10/03/2019 VERTEX PHARMACEUTICALS INCORPORATED SYMDEKO (Drug) Travel and Lodging In-kind items and services $170.79 General
Category: CYSTIC FIBROSIS

About Christopher Fortner, MD, PHD

Christopher Fortner, MD, PHD is a Pediatric Pulmonology healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1104084078.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Fortner, MD, PHD has received a total of $59,815 in payments from pharmaceutical and medical device companies, with $269.99 received in 2024. These payments were reported across 79 transactions from 8 companies. The most common payment nature is "Travel and Lodging" ($22,318).

Practice Information

  • Specialty Pediatric Pulmonology
  • Other Specialties Pediatric Pulmonology
  • Location Syracuse, NY
  • Active Since 05/28/2008
  • Last Updated 08/31/2012
  • Taxonomy Code 2080P0214X
  • Entity Type Individual
  • NPI Number 1104084078

Products in Payments

  • SYMDEKO (Drug) $8,295
  • TRIKAFTA (Drug) $5,727
  • Cayston (Drug) $3,326
  • ORKAMBI (Drug) $2,515
  • iExaminer Image Reader (Device) $325.00
  • TOBI PODHALER (Drug) $155.82
  • Creon (Drug) $102.67
  • WAKIX (Drug) $84.99
  • BRONCHITOL (Drug) $63.71
  • PERTZYE (Drug) $13.65

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Pulmonology Doctors in Syracuse